To evaluate the association between skeletal muscle mineral balance and effect of antihypertensive treatment, 37 patients with essential hypertension, randomly treated with either Esinoprif or bendrofluazide, were investigated with skeletal muscle biopsi& before and after 6 month; of treatment. The ratio between calcium and magnesium concentrations in skeletal muscie ptior to treatment predided the blood pressure response during active treatment (r = -0.38, P < 421. During treatment the change in blood pressure was related deficient intracellular magnesium con'ient, together with an increased intracellular calciuin concentration, has beert ohserr~ed in er~~hrocytes and p!atclets from hlzpertensive subjects.. 'The conditions in eryttilocytes and platelets may not, however, reelect the conditions in other tissues."
TABLE 1. MINERAL CHARACTEKISTICS OF THE HYPERTENSIVE PATIENTS (N = 37) DURING THE
nificantly correlated with each other (r = 0.64, P <
INITIAL FLACEBO RUN-IN (0). ADJUSTED MEANS
.OOOl) at baseline, as were the observed changes in In the lisinopril-treated patients, the Ca/Mg ratio in skeletal muscle at baseline predicted the changes nective tissue, and immediately frozen and stored in nitrogen at -70" until the muscle electrolyte status was analyzed by pptic emission spectroscopy (ICI'-OES, Diospectron, Tagarp, Sweden). The coefficient of variability for the OES method in muscle biopsy specimens is 0.5 to 3%.
Skewed data distributions were logarithmically transformed before analysis. Adjusted means are presented, since least square means constitute the basis of tests and estimates in the analysis, and the significance levels given correspond to these calculations. A two-way analysis of variaxe model was used to test changes within and between groups over time. Changes in the total study group are presented if there was no statistica!ly s$nificant (P < .05) difference between the observed changes in the two separate drug-treated groups. Relationships between variables were analyzed by calculations of Pearson's correlation coefficients. j
RESULTS
Moderate nonsignificant alterations in skeletal mu.scle mineral concentrations were observed during treatment with bendrofluazide. Treatment with lisinopril did not significantly affect the mineral status in skeletal muscle (Table 1) .
III muscle tissue, a strong correlation was noted between the K and Mg concentrations (r = 0.92, P < .OOOl 1, and also between the changes in these concentrations during treatment (r = 0.98, P < .OOOl 1. The muscle Na /K ratio and Ca /Mg ratio were also sig.. in both positions, and in DBP in the supine position, were correlated to the &angc ir-muscle Ca /Mg ratio during the treatment period (r = 0.50 to 0.61, P < .Ol to .05). In the bendrofluazide-treated patients these correlations were not significant, but as no statistically significant differences were found between the two drug effects, the two treatment groups were also analyzed together (Figure 2 ). There were no signific?E! correlations between changes in blood pressure and changes in muscle Na /K ratio.
DISCUSSION
The present study showed that the Ca/Mg ratio in skeletal muscle is associated with blood pressure regulation, as a relative increase in the magnesium content in skeletal muscle, compared with the calcium contem, was associated with a fairly pronounced decrease in blood pressure during treatment. Furthermore, the Ca /Mg ratio in skeletal muscle was found to be a predictor for the blocd pressure response to antihypertensive treatment.
In previous studies, Lindner et al noted a correlation between the calcium concentration in erythrocytes and blaod pressure, and observed a reduced calcium concentration in erythrocytes from patients in whom the blood pressure was reduced during treatment with antihypertensive drugs such as lisino- pril, hydrochlorothiazide, and nifedipine.' Similar findings have been described by Erne et a1.3 Paolisso et al treated elderly nonobese hypertensive subjects with magnesium and nifedipine infusion and noted a correlation between the changes in the Ca/Mg ratio in erythrocytes and the decline in blood pressure.7 Recently, Resnick et al reported lower intracellular free magnesium levels in skeletal muscle of subjects with essential hypertension compared with normotensives.' Calcium is a primary regulator of contraction both in skeletal and in vascular smooth muscle.' Magnesium has been shown to have relaxing effects on different vascular preparations, exerted by blocking of calcium entry into cells.'3," Thus, assuming that parallel mineral changes occur in skeletal and vascular smooth muscle, a reduced Ca/Mg ratio would theoretically lead to vasodilatation. Why the association between the changes in calcium and magnesium concentrations in skeletal muscle and the antihypertensive response to lisinopril was more pronounced than that for the thiazide is not known, but the ability of diuretic therapy to concommitantly lower blood pressure and deplete magnesium may help to explain the poor correlation between changes in blood pressure with changes in Ca /Mg ratios. This is emphasized by the work of Dyckner and Wester, who showed that magnesium supplementation given to diuretic-treated hypertensives both elevated muscle magnesium content and further lowered blood pressure.",i3
It has previously been found that an adequate intracellular magnesium concentration is necessary for the intracellular potassium balance,14-'" as the Na + -K + -pump transporting potassium into the intraceilular space is conducted by magnesium-dependent phosphorylatio;l,'r and AS magnesium inhibits the K' efflux via potassium channels.'s*'s The close relationship observed in the present study confirms these observations. In summary, an association between the calcium and magnesium balance in skeletal muscle and the blood pressure response to antihypertensive treatment was found in the present study, suggesting that ion balance is involved in blood pressure regulation. 
